Evoke Pharma, Inc.
EVOK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,156 | -$1,571 | -$1,306 | -$1,193 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $104 | $84 | $0 |
| Change in WC | $384 | $758 | $82 | -$451 |
| Other Non-Cash | $250 | $144 | $142 | $404 |
| Operating Cash Flow | -$522 | -$565 | -$998 | -$1,240 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $39 | $0 | $25 | $3,498 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $39 | $0 | $25 | $3,498 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$483 | -$565 | -$973 | $2,258 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,059 | $12,624 | $13,597 | $11,339 |
| End Cash | $11,576 | $12,059 | $12,624 | $13,597 |
| Free Cash Flow | -$522 | -$565 | -$998 | -$1,240 |